Gossamer Bio, Inc. (GOSS)
2.13
+0.02
(+0.95%)
USD |
NASDAQ |
Feb 20, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio SG&A Expense (Quarterly) : 9.39M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| XOMA Royalty Corp. | 9.734M |
| Rezolute, Inc. | 9.873M |
| Axsome Therapeutics, Inc. | 150.24M |
| Crinetics Pharmaceuticals, Inc. | 52.26M |